Healthcare -
Biotechnology - NASDAQ - US
$ 1.02
-2.17 %
$ 57.6 M
Market Cap
-0.58
P/E
PRLD - OPERATING INCOME
Operating Income PRLD - Prelude Therapeutics Incorporated
-140 M
LAST VALUE
-6.34%
2 YEAR CAGR
-37.81%
5 YEAR CAGR
0.00%
10 YEAR CAGR